Daniela De Angelis

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	10936	5698
h-endeksi	54	32
i10-endeksi	137	92

1700

850

425

1275

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202540 30 41 42 74 66 84 124 120 201 267 279 354 405 514 502 578 630 638 651 851 1603 1425 1010 134

Genel erişim

Tümünü görüntüle

105 makale

5 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Anne M PresanisMRC Biostatistics Unit, University of Cambridgemrc-bsu.cam.ac.uk üzerinde doğrulanmış e-posta adresine sahip
M Hickmanbristol.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Michael SweetingAstraZenecaastrazeneca.com üzerinde doğrulanmış e-posta adresine sahip
Richard PebodyUKHSAukhsa.gov.uk üzerinde doğrulanmış e-posta adresine sahip
Xu-Sheng Zhangmathematical modeller, PHEphe.gov.uk üzerinde doğrulanmış e-posta adresine sahip
Ben CooperOxford Universitytropmedres.ac üzerinde doğrulanmış e-posta adresine sahip
Thomas HouseDepartment of Mathematics, University of Manchestermanchester.ac.uk üzerinde doğrulanmış e-posta adresine sahip
V T FarewellMRC Biostatistics Unitbf.mailc.net üzerinde doğrulanmış e-posta adresine sahip
Marc LipsitchDepartment of Epidemiology, Harvard School of Public Healthhsph.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Brian TomProgramme Leader, MRC Biostatistics Unit, University of Cambridgemrc-bsu.cam.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Malcolm PriceAssociate Professor of Biostatistics and Epidemiology, Canadian University Dubaibham.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Steven RileyImperial College Londonimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Richard G WhiteProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical Medicinelshtm.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Tim ChadbornHead of Behavioural Insights and Evaluation Lead, Public Health Englandphe.gov.uk üzerinde doğrulanmış e-posta adresine sahip
Carrie ReedCenters for Disease Control and Preventioncdc.gov üzerinde doğrulanmış e-posta adresine sahip
Benjamin AuditLaboratoire de Physique, Ecole Normale Supérieure de Lyonens-lyon.fr üzerinde doğrulanmış e-posta adresine sahip
Sophia TsokaKing's College Londonkcl.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Christine A McGarrigleTrinity College Dublintcd.ie üzerinde doğrulanmış e-posta adresine sahip
david spiegelhalterCambridge Universitystatslab.cam.ac.uk üzerinde doğrulanmış e-posta adresine sahip

Takip et

Daniela De Angelis

Professor, Programme Leader at MRC Biostatistics Unit, University of Cambridge

mrc-bsu.cam.ac.uk üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Bayesian statistics. Evidence synthesis. Statistical inference in infectious diseases models.


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... The Lancet 399 (10332), 1303-1312, 2022	1281	2022
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022	939	2022
Isaac Newton Institute IID collaboration (2015) Modelling infectious disease dynamics in the complex landscape of global health H Heesterbeek, RM Anderson, V Andreasen, S Bansal, D De Angelis, ... Science 347, 6227, 0	794*
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence KME Turner, S Hutchinson, P Vickerman, V Hope, N Craine, N Palmateer, ... Addiction 106 (11), 1978-1988, 2011	421	2011
The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis AM Presanis, D De Angelis, ... PLoS medicine 6 (12), e1000207, 2009	383	2009
Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment J Kimber, L Copeland, M Hickman, J Macleod, J McKenzie, D De Angelis, ... Bmj 341, 2010	239	2010
Modeling the percolation of annotation errors in a database of protein sequences WR Gilks, B Audit, D De Angelis, S Tsoka, CA Ouzounis Bioinformatics 18 (12), 1641-1649, 2002	212	2002
Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model MJ Price, AE Ades, D De Angelis, NJ Welton, J Macleod, K Soldan, ... American journal of epidemiology 178 (3), 484-492, 2013	196	2013
A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: application to AIDS prediction in England and Wales OO Aalen, VT Farewell, D de Angelis, NE Day, O Nöel Gill Statistics in medicine 16 (19), 2191-2210, 1997	183	1997
HIV incidence in men who have sex with men in England and Wales 2001–10: a nationwide population study PJ Birrell, ON Gill, VC Delpech, AE Brown, S Desai, TR Chadborn, ... The Lancet infectious diseases 13 (4), 313-318, 2013	177	2013
Risk of hospital admission for patients with SARS-CoV-2 variant B. 1.1. 7: cohort analysis T Nyberg, KA Twohig, RJ Harris, SR Seaman, J Flannagan, H Allen, ... bmj 373, 2021	159	2021
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS … A Babiker, S Darby, D De Angelis, D Kwart, K Porter, V Beral, ... Lancet 355 (9210), 2000	151	2000
Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London PJ Birrell, G Ketsetzis, NJ Gay, BS Cooper, AM Presanis, RJ Harris, ... Proceedings of the National Academy of Sciences 108 (45), 18238-18243, 2011	150	2011
HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact NK Martin, GR Foster, J Vilar, S Ryder, M E Cramp, F Gordon, JF Dillon, ... Journal of viral hepatitis 22 (4), 399-408, 2015	132	2015
Estimating HIV incidence, time to diagnosis, and the undiagnosed HIV epidemic using routine surveillance data A van Sighem, F Nakagawa, D De Angelis, C Quinten, D Bezemer, ... Epidemiology (Cambridge, Mass.) 26 (5), 653, 2015	127	2015
HCV Treatment as Prevention in People Who Inject Drugs–testing the evidence M Hickman, D De Angelis, P Vickerman, S Hutchinson, N Martin Current opinion in infectious diseases 28 (6), 576, 2015	119	2015
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis RJ Harris, M Ramsay, VD Hope, L Brant, M Hickman, GR Foster, ... The European Journal of Public Health 22 (2), 187-192, 2012	119	2012
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021	115	2021
Assessing the impact of national anti-HIV sexual health campaigns: trends in the transmission of HIV and other sexually transmitted infections in England A Nicoll, G Hughes, M Donnelly, S Livingstone, D De Angelis, K Fenton, ... Sexually Transmitted Infections 77 (4), 242-247, 2001	115	2001
Towards elimination of HIV transmission, AIDS and HIV‐related deaths in the UK AE Brown, S Nash, N Connor, PD Kirwan, D Ogaz, S Croxford, ... HIV medicine 19 (8), 505-512, 2018	113	2018

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar